Regulatory status: unapproved and research-use-only As of the preparation of this article, BPC-157 has not received marketing authorization from the US Food and Drug Administration, the European Medicines Agency, or equivalent national regulators for any therapeutic indication
178,179,180 In 2004, the FDA approved the first aptamer drug, pegaptanib (Macugen), to treat choroidal neovascularization caused by neovascular age-related macular degeneration (AMD)
Secure Checkout & Protected Transactions: We prioritise the security of your personal information
J., Zubair-Nizami, Z., Langohr, I
Glutathione is an antioxidant thats made up of three amino acids: glycine, glutamic acid and cysteine
Nevertheless, patients with HER -2-positive breast cancer can develop resistance to targeted HER-2 therapy, such as trastuzumab, after several years 86